Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of opioids.